Genetic alterations and their clinical implications in DLBCL
Y Miao, LJ Medeiros, Y Li, J Li, KH Young - Nature reviews Clinical …, 2019 - nature.com
Diffuse large B cell lymphoma (DLBCL) is a highly heterogeneous lymphoid neoplasm with
variations in gene expression profiles and genetic alterations, which lead to substantial …
variations in gene expression profiles and genetic alterations, which lead to substantial …
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma
M Pi, H Kuang, C Yue, Q Yang, A Wu, Y Li… - Drug Resistance …, 2022 - Elsevier
Cancer cell metabolism including aerobic glycolysis, amino acid and fatty acid metabolism,
has been extensively studied. Metabolic reprogramming is a major hallmark of cancer …
has been extensively studied. Metabolic reprogramming is a major hallmark of cancer …
[HTML][HTML] Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
Axicabtagene ciloleucel (axi-cel) is an anti-CD19 chimeric antigen receptor (CAR) T cell
therapy approved for relapsed/refractory large B cell lymphoma (LBCL) and has treatment …
therapy approved for relapsed/refractory large B cell lymphoma (LBCL) and has treatment …
[HTML][HTML] Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
WH Wilson, GW Wright, B Hodkinson… - Cancer cell, 2021 - cell.com
In diffuse large B cell lymphoma (DLBCL), tumors belonging to the ABC but not GCB gene
expression subgroup rely upon chronic active B cell receptor signaling for viability, a …
expression subgroup rely upon chronic active B cell receptor signaling for viability, a …
Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL
SK Lim, CC Peng, S Low, V Vijay, A Budiman… - Leukemia, 2023 - nature.com
DLBCL is the most common lymphoma with high tumor heterogeneity. Treatment
refractoriness and relapse from R-CHOP therapy in patients remain a clinical problem …
refractoriness and relapse from R-CHOP therapy in patients remain a clinical problem …
Genome sequencing of the sweetpotato whitefly Bemisia tabaci MED/Q
W Xie, C Chen, Z Yang, L Guo, X Yang, D Wang… - …, 2017 - academic.oup.com
The sweetpotato whitefly Bemisia tabaci is a highly destructive agricultural and ornamental
crop pest. It damages host plants through both phloem feeding and vectoring plant …
crop pest. It damages host plants through both phloem feeding and vectoring plant …
VPS13A is closely associated with mitochondria and is required for efficient lysosomal degradation
S Muñoz-Braceras, AR Tornero-Écija… - Disease models & …, 2019 - journals.biologists.com
Members of the VPS13 family are associated with various human diseases. In particular, the
loss of function of VPS13A leads to chorea-acanthocytosis (ChAc), a rare …
loss of function of VPS13A leads to chorea-acanthocytosis (ChAc), a rare …
Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies
Aberrant skipping of coding exons in CD19 and CD22 compromises the response to
immunotherapy in B-cell malignancies. Here, we showed that the MS4A1 gene encoding …
immunotherapy in B-cell malignancies. Here, we showed that the MS4A1 gene encoding …
[HTML][HTML] Multifaceted role of PRDM proteins in human cancer
The PR/SET domain family (PRDM) comprise a family of genes whose protein products
share a conserved N-terminal PR [PRDI-BF1 (positive regulatory domain I-binding factor 1) …
share a conserved N-terminal PR [PRDI-BF1 (positive regulatory domain I-binding factor 1) …
[HTML][HTML] Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment
S Li, Y Ma, Y Tan, X Ma, M Zhao, B Chen… - Cell death & …, 2018 - nature.com
Circular RNAs (circRNAs) are a novel class of powerful regulators in gene expression and
participate in the pathogenesis of many diseases, including cancer. However, little is known …
participate in the pathogenesis of many diseases, including cancer. However, little is known …